DEF: American Vanguard Corp. Schedules 2026 Annual Meeting
Proxy Statement
American Vanguard Corporation announces its 2026 Annual Meeting of Stockholders, detailing proposals for director elections, auditor ratification, and executive compensation votes.
Summary
- American Vanguard Corporation (AVD) has issued its Notice of 2026 Annual Meeting of Stockholders, scheduled for June 3, 2026, as a virtual meeting.
- Key proposals include the election of seven directors, ratification of Deloitte & Touche LLP as the independent auditor for the fiscal year ending December 31, 2026, an advisory vote on the frequency of executive compensation votes, and an advisory vote on executive compensation itself.
- The record date for determining stockholders entitled to vote is April 10, 2026, with 34,244,580 shares outstanding.
- Proxy materials will be available starting April 23, 2026, and can be accessed along with the 2025 Annual Report on Form 10-K at www.proxyvote.com.
- The meeting will be conducted virtually, requiring a 16-digit control number for participation, voting, and question submission.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral filing, primarily focused on routine corporate governance matters like the annual meeting and director elections, with no significant new financial or strategic information.
Positives
- The company is holding its annual meeting to ensure shareholder engagement and governance.
- The board has nominated a slate of directors with diverse and relevant experience.
- Deloitte & Touche LLP, a reputable accounting firm, is proposed for reappointment.
- The company continues to engage with shareholders on executive compensation through advisory votes.
- The company has a clear process for stockholder nominations and proposals, with defined deadlines.
Negatives
- The company's Total Shareholder Return (TSR) over one, three, and five-year periods has been below the 25th percentile of its proxy peers.
- Executive compensation for 2025 was below the 25th percentile of proxy peers, with target equity compensation and total direct compensation near the zero percentile.
- The company experienced flat financial performance year-over-year in 2025 amidst slumping market conditions.
- Two Section 16 filings were delinquent in fiscal 2025 for certain officers and directors.
Risks
- Changes in environmental, governmental, or other regulations.
- U.S. Environmental Protection Agency preliminary findings and related public statements and registration review and petitions.
- Product and environmental liability.
- Pesticide and per- and polyfluoroalkyl substances legislation, lawsuits, and challenges.
- Global supply chain disruptions and tariffs.
- Artificial intelligence impacts.
- Global economic fluctuations and volatility.
- The company's ability to borrow under its credit facility and the impact of interest rates and inflation on the debt market.
Future Outlook
The filing does not contain specific forward-looking financial guidance but discusses the company's strategy to position itself for long-term success through business improvement plans, commercial, operational, digital, and organizational initiatives, and new product development.
Management Comments
- The company believes that its human capital strategy prioritizes collaborative and consistent execution to fulfill commitments, fostering a performance-driven culture.
- Management philosophy prioritizes collaborative and consistent execution to fulfill commitments, fostering a performance-driven culture.
- The company believes that its executive compensation reflects a commitment toward requiring accountability for results among its executive team and is consistent with pay-for-performance.
- The Board believes that the engagement of Deloitte & Touche LLP is in the best long-term interest of the Company and its stockholders.
Industry Context
StockSavvy.ai notes that American Vanguard Corporation operates in a specialized industry where identifying direct competitors for compensation benchmarking is challenging, often requiring the use of broader chemical sector peers.
Comparison to Industry Standards
- The median revenue for the identified proxy peers (11 publicly traded companies in the chemicals sector) was $619 million, with a median market capitalization of $875 million and median enterprise value of $1,338 million.
- The company's CEO base salary ($650K) was below the 25th percentile for salaries among proxy peers.
- The CEO's target bonus amount was below the 25th percentile, and the actual bonus amount ($236K) was at the zero percentile of target bonus for proxy peers.
- The CEO's target total cash compensation was below the 25th percentile, while actual total cash ($877.5K) was at the zero percentile of target total cash for proxy peers.
- Equity granted to the CEO in 2025 was $0, placing it at the zero percentile of proxy peers.
- Annualized total direct compensation for the CEO, both at target and actual basis, was at or near the zero percentile of proxy peers.
- Compensation for other NEOs was similarly positioned relative to proxy peers as that of the CEO.
- The median board size among the company's proxy peers was seven directors, with six non-management directors, aligning with AVD's board size reduction.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Director | Scott Baskin | Patrick E. Gottschalk | 2026-06-03 | Retirement of Scott Baskin and appointment of Patrick Gottschalk as Chair. |
| Director | Emer Gunter | 2026-06-03 | Not seeking reelection. | |
| Director | Carmen Tiu de Mino | 2026-06-03 | Not seeking reelection. | |
| Director | Rubin J. McDougal | 2026-04-10 | Nominated as per requirements of the 1L Term Loan. | |
| Director | Douglas A. Kaye III | 2024-12-01 | Joined as Chief Executive Officer. | |
| Chief Legal Officer, General Counsel & Secretary | Timothy J. Donnelly | 2024-06-01 | Appointed to role. | |
| Chief Human Resources Officer | Shirin Khosravi | 2024-12-01 | Appointed to role. |
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Board Size Reduction | The size of the Board has been fixed at seven directors, down from nine, effective as of the Annual Meeting, in accordance with the 1L Term Loan. | 2026-04-10 | Aligns with industry median board size for similarly sized public companies and meets lender requirements. |
| Director Nomination Requirement | The Lenders under the 1L Term Loan required the appointment of an independent director designated by Centerbridge. | 2026-04-10 | Introduces a director nominated by a lender, potentially influencing strategic oversight. |
| Board Refreshment | Three directors are not seeking reelection, and one new director is nominated, leading to a significant reduction in average director tenure. | 2026-06-03 | Aims to bring fresh perspectives and skills to the board, with an average tenure of 1.6 years post-election. |
| Chair Appointment | Patrick Gottschalk will serve as Chair of the Board, succeeding Scott Baskin. | 2026-06-03 | Ensures continued independent leadership of the board. |
Legal Proceedings
- The company mentions potential litigation related to pesticide and per- and polyfluoroalkyl substances (PFAS) legislation.
- The company is subject to general business regulations, including taxes.
Stakeholder Impact
- Shareholders: Voting on director elections, auditor ratification, and executive compensation; potential impact from board changes and compensation structure.
- Employees: Continued focus on human capital resources, competitive benefits, and employee engagement; retention payments made to certain executives.
- Lenders: Requirements of the 1L Term Loan have led to board size reduction and director nomination changes.
Next Steps
- Stockholders to vote on the election of directors, ratification of the independent auditor, frequency of advisory votes on executive compensation, and advisory vote on executive compensation.
- The Board will act on any director resignation tenders within 90 days of certification of results.
- The company will publish voting results on a Form 8-K within four business days after the Annual Meeting.
- The company will move its headquarters effective on or about May 13, 2026.
Key Dates
| Date | Description |
|---|---|
| 2026-04-10 | Record date for determining stockholders entitled to notice of, and to vote at, the Annual Meeting. |
| 2026-04-23 | Approximate date proxy materials are first sent to stockholders. |
| 2026-06-02 | Deadline for submitting proxy votes via Internet or phone. |
| 2026-06-03 | Date of the 2026 Annual Meeting of Stockholders. |
| 2026-05-13 | Effective date for the company's headquarters move. |
Recommendation
holdThe filing is routine and primarily concerns the annual meeting and governance matters. While there are no immediate negative financial disclosures, the company's below-peer TSR and compensation levels suggest a need for performance improvement before a more positive recommendation can be made. The ongoing business improvement initiatives warrant a 'hold' to observe their impact.
Keywords
Proxy Statement, Annual Meeting, American Vanguard Corporation, Director Election, Executive Compensation, Auditor Ratification, Stockholder Vote, Corporate Governance
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.